Rethinking Clinical Trials with Faster AI-Driven Decision Making
Drug development remains one of the most capital-intensive activities in life sciences. A 2021 peer-reviewed study published in Clinical and Translational…
•


Explore articles and reports related to artificial intelligence in transportation, including coverage of self-driving cars, public transportation systems, and more.
Drug development remains one of the most capital-intensive activities in life sciences. A 2021 peer-reviewed study published in Clinical and Translational…
•

Life sciences enterprises are caught in a widening gap. The pace of R&D, manufacturing, and data-driven decision-making is accelerating, but the…
•

This interview analysis is sponsored by AcuityMD and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

Talent data fragmentation has emerged as a foundational constraint on enterprise HR’s ability to make strategic workforce decisions, persisting because organizations…
•

Life sciences are over‑funding AI and under‑funding the data maturity required to scale it. This imbalance is turning a potential R&D…

•

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems…

•
